Electronic monitoring of medication adherence in early maintenance phase treatment for pediatric leukemia and lymphoma: Identifying patterns of nonadherence

Journal of Pediatric Psychology

Volumn 40, Issue 1, 2015, Pages 75-84

  Rohan, Jennifer M ^a,b   Drotar, Dennis ^a,b   Alderfer, Melissa ^c   Donewar, Crista Wetherington ^d   Ewing, Linda ^e   Katz, Ernest R ^f   Muriel, Anna ^g  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Children's Hospital Medical Center   (United States)

^e Department of Psychiatry   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g Department of Pediatric Oncology   (United States)

Author keywords

adherence; cancer and oncology; research design and methods; statistical applications

Indexed keywords

MERCAPTOPURINE;

ADOLESCENT; CHILD; CLINICAL TRIAL; DRUG MONITORING; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

6-MERCAPTOPURINE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 84925198469     PISSN: 01468693     EISSN: 1465735X     Source Type: Journal    
DOI: 10.1093/jpepsy/jst093     Document Type: Article

References (28)

1. Bhatia, S., Lanr, W., Shangguan, M., Hageman, L., Schaible, A. N., Carter, A. R., Wong, F. L. (2012). Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: A report from the children,s oncology group. Journal of Clinical Oncology, 30, 2094-2101
2. Bleyer, A. (2011). Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans. Journal of Adolescent and Young Adult Oncology, 1, 37-42
3. Brown, M., & Yabroff, K. R. (2006). Economic impact of cancer in the United States. In D. Schottenfeld, & J. F. Fraumeni (Eds.), Cancer epidemiology and prevention (pp. 202-216). New York, NY: Oxford University Press, Inc
4. Cortina, S., Somers, M., Rohan, J. M., & Drotar, D. (2013). Clinical effectiveness of comprehensive psychological intervention for nonadherence to medical treatment: A case series. Journal of Pediatric Psychology, 38, 649-663. doi:10.1093/jpepsy/jss175
5. Derijks, L. J., Gilissen, L. P., Engels, L. G., Bos, L. P., Bus, P. J., Lohman, J. J., Hooymans, P. M. (2004). Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: Implications for therapy. Therapeutic Drug Monitoring, 26, 311-318
6. Festa, R. S., Tamaroff, M. H., Chasalow, F., & Lanzkowsky, P. (1992). Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. The Journal of Pediatrics, 120, 807-811
7. Fishman, M., & Mrozek-Orlowsk, M. (1999). Cancer chemotherapy guidelines and recommendations for practice. Pittsburgh, PA: Oncology Nursing Press
8. Ingerski, L. M., Hente, E. A., Modi, A. C., & Hommel, K. A. (2011). Electronic measurement of medication adherence in pediatric chronic illness: A review of measures. Journal of Pediatrics, 159, 528-534
9. Kato, Y., Matsushita, T., Uchida, H., Egi, S., Yokoyama, T., & Mohri, K. (1992). Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: Partial avoidance of ,,firstpass, metabolism. European Journal of Clinical Pharmacology, 42, 619-622
10. Kenna, L. A., Labbé, L., Barrett, J. S., & Pfister, M. (2005). Modeling and simulation of adherence: Approaches and applications in therapeutics. The AAPS Journal, 7, E390-E407
11. Kennard, B. D., Stewart, S. M., Olvera, R., Bawdon, R. E., OhAilin, A., Lewis, C. P., & Winick, N. J. (2004). Nonadherence in adolescent oncology patients: Preliminary data on psychological risk factos and relationships to outcome. Journal of Clinical Psychology in Medical Settings, 11, 31-39
12. Kondryn, H. J., Edmondson, C. L., Hill, J. W., & Eden, T. O. B. (2010). Treatment non-Adherence in teenage and young adult patients with cancer. Lancet Oncology, 12, 100-108
13. Lau, R. C. W., Matsui, D., Greensberg, M., & Koren, G. (1998). Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Medical and Pediatric Oncology, 30, 85-90
14. Lennard, L., Welch, J., & Lilleyman, J. (1995). Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: A possible indicator of non-compliance? British Journal of Cancer, 72, 1004
15. Modi, A. C., Rausch, J. R., & Glauser, T. A. (2011). Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. Journal of the Americal Medical Association, 305, 1669-1676
16. Nagin, D. S. (2005). Group-based modeling of development. Cambridge, MA: Harvard University Press
17. National Cancer Institute. (2008). National Cancer Institute: Factsheet: Childhood Cancers. National Institutes of Health. Retrieved from http://www. cancer.gov/cancertopics/factsheet/sites-Types/child hood/print
18. Pritchard, M. T., Butow, P. N., Stevens, M. M., & Duley, J. A. (2006). Understanding medication adherence in pediatric acute lymphoblastic leukemia: A review. Journal of Pediatric Hematology/Oncology, 28, 816-823
19. Quittner, A. L., Modi, A. C., Lemanek, K. L., Ievers-Landis, C. E., & Rapoff, M. A. (2008). Evidence-based assessment of adherence to medical treatments in pediatric psychology. Journal of Pediatric Psychology, 33, 916-936; discussion 937-938
20. Reddy, K. S., & Perkins, S. L. (2004). Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms. American Journal of Clinical Pathology, 122, S3
21. Relling, M. V., Hancock, M. L., Boyett, J. M., Pui, C. H., & Evans, W. E. (1999). Prognostic importnace of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood, 93, 2817-2823
22. Riekert, K. A., & Rand, C. (2002). Electronic monitoring of adherence: When is high-Tech the best? Journal of Clinical Psychology in Medical Settings, 9, 25-34
23. Rohan, J., Drotar, D., McNally, K., Schluchter, M., Riekert, K., Vavrek, P., Kercsmar, C. (2010). Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: An application of growth curve analysis. Journal of Pediatric Psychology, 35, 394-404
24. Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. A Cancer Journal for Clinicians, 59, 56-64
25. Singer, J. D., & Willet, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford Press
26. Tebbi, C. K. (2006). Treatment compliance in childhood and adolescence. Cancer, 71, 3441-3449
27. Traore, F., O,Riordan, M. A., Myers, C., Groth, K., Hoff, A., Angiolillo, A., Kodish, E. (2006). How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolites. Pediatric Blood and Cancer, 46, 187-192
28. Weiss, L. M., Bindl, J. M., Picozzi, V. J., Link, M. P., & Warnke, R. A. (1986). Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood, 67, 474-478